Mon, October 08 2007 10:00 AM
Promega and amaxa Co-promote Luminescence-based Assays and Transfection
amaxa and Promega, the leading supplier of bioluminescent tools (e.g. luciferase vectors) and innovative reporter assays, have agreed to develop applications to monitor cell signalling events in difficult-to-transfect cells such as primary cells, stem cells and cancer cells.
“Luciferase reporters are routinely used to monitor gene expression and are ideal tools for high-throughput screening, RNAi-mediated gene regulation and detection of cellular metabolism and viability. The combination of Promega’s luciferase products and Amaxa’s technology will enable the generation of stable cell lines and bioluminescent cell-based assays even for primary cells” said John Watson, Director of Cellular Analysis, Promega.
More information on nucleofection of luciferase constructs
